Pulmoqune Therapeutics
San Diego, US · Founded 2020 · Delaware corporation
Founders & leadership
SS
Sarah Schlesinger, MDNamed on SEC filing
PB
Peter B. FinnNamed on SEC filing
RH
Robert HillmanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 1 round · 2020
▶$5.5MraisedApr 2020 · 2 investors · Other Health CareRule 506(b)
▶$5.5MraisedApr 2020 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sarah Schlesinger, MDDirector
- Peter B. FinnExecutive Officer
- Robert HillmanExecutive Officer, Director
- Offering amount
- $5.5M
- Amount sold
- $5.5M
- Minimum investment
- $500K
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Pulmoqune Therapeutics raised?
- Pulmoqune Therapeutics has disclosed $5.5M raised across 1 round.
- Where is Pulmoqune Therapeutics headquartered?
- Pulmoqune Therapeutics is headquartered in San Diego, US.